Clinigen
Clinigen Global Access Programs specializes in the consultancy, development, management and implementation of access programs across the product lifecycle for biotechnology and pharmaceutical companies.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Inizio
Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.
Red Thread Market Access Ltd
Blending brilliant writing with in-depth market access and reimbursement expertise
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
5 ways to engage HCPs in medical education
White Papers and Resources | February 16, 2024 | Wiley
How to bring credibility, trust and flexibility into your medical education programs
Navigating challenges of MedTech research with rare-disease patients
White Papers and Resources | February 16, 2024 | Inizio
Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.
Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series
Press Releases | February 15, 2024 | Medscape Education
What are some of the biggest gaps that women face in healthcare today? “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....
Have you heard from her?
Press Releases | February 15, 2024 | Medscape Education
We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...
Clinical trial considerations: Why diversity matters…
White Papers and Resources | February 15, 2024 | Cuttsy + Cuttsy
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...
Rare Disease Diagnostic Odyssey
Videos and Podcasts | February 14, 2024 | Medscape Education
Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions
Press Releases | February 14, 2024 | Petauri Evidence
Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.
The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid
White Papers and Resources | February 14, 2024 | Petauri Evidence
Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...
Product launch: What market research when?
White Papers and Resources | February 14, 2024 | Inizio
Get the insights you need, when you need them, for your product launch planning
Clinical trial considerations: Why digital matters…
White Papers and Resources | February 14, 2024 | Cuttsy + Cuttsy
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.